MDB Capital Holdings (MDBH) Status Update summary
Event summary combining transcript, slides, and related documents.
Status Update summary
15 Jan, 2026IPO update and market context
The IPO is moving forward with a $4 per share price, targeting $15 million in capital, and is expected to begin trading next week pending final SEC approval.
The offering is structured to be capital-light, with only $6 million previously invested and $13–14 million in government funding to date.
The company is transitioning from technology development to product commercialization, targeting four key markets.
Significant insider ownership will remain post-IPO, with MDB Holdco and founders retaining nearly 77% combined.
Introduction of long-term investor right (LTIR)
A new LTIR is attached to 3.75 million IPO shares, incentivizing investors to hold shares for at least two years.
The LTIR allows holders to receive up to one additional share per IPO share if the stock does not double within two years.
The right is non-transferable and requires continuous ownership, with exceptions for certain life events.
If the stock trades above $8 for 20 days, the LTIR is canceled; otherwise, a formula determines the number of additional shares granted.
The LTIR is designed to provide downside protection and encourage long-term investment.
Mechanics and investor considerations
To qualify for the LTIR, shares must be registered with the transfer agent or held at designated brokerages for two years.
The formula for additional shares is based on the difference between $8 and the average six-month share price over two years.
If the share price remains at $4, investors could double their shares, effectively lowering their cost basis to $2.
The LTIR only applies to IPO shares, not to insider or pre-IPO holdings.
Demonstration of continuous ownership is required to claim the LTIR benefit.
Latest events from MDB Capital Holdings
- Public venture model delivers liquid, tax-advantaged access to high-growth companies.MDBH
Investor presentation16 Mar 2026 - Invizyne IPO, deep tech pipeline, and investor growth drive expansion despite higher losses.MDBH
Q3 202412 Jan 2026 - eXoZymes IPO and deconsolidation clarify results as platform and investor base expand.MDBH
Q4 202426 Dec 2025 - Shareholders will vote on directors and auditor, with control held by Class B shares and strong governance oversight.MDBH
Proxy Filing2 Dec 2025 - Shareholders will vote on directors, executive pay, auditor ratification, and governance policies.MDBH
Proxy Filing2 Dec 2025 - Q2 2025 net loss rose to $8.25M as focus shifts to profitable IPOs and a PatentVest spin-off.MDBH
Q2 202523 Nov 2025 - Scaling launches and major equity deals position for upside as market recovery is expected.MDBH
Q3 202521 Nov 2025 - Q1 2025 saw strong financings, platform growth, and a volatile portfolio amid macro risks.MDBH
Q1 202512 Nov 2025 - Scaling curated public ventures, prioritizing leadership and innovation in small-cap IPOs.MDBH
LD Micro Main Event XIX Investor Conference21 Oct 2025